Is JNJ Stock A Buy As Covid Vaccinations Resume Post Blood-Clot Scare?

Is JNJ Stock A Buy As Covid Vaccinations Resume Post Blood-Clot Scare?
·6 min read

Is JNJ stock a buy after U.S. regulators recommended vaccinations resume with Johnson & Johnson's Covid vaccine following worries of blood clots? Shares are forming a flat base.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting